Back to Search Start Over

Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models.

Authors :
Ma X
Botros A
Yun SR
Park EY
Kim O
Park S
Pham TH
Chen R
Palaniappan M
Matzuk MM
Kim J
Fernández FM
Source :
Frontiers in chemistry [Front Chem] 2024 Jan 08; Vol. 11, pp. 1332816. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).
Publication Year :
2024

Abstract

No effective screening tools for ovarian cancer (OC) exist, making it one of the deadliest cancers among women. Considering that little is known about the detailed progression and metastasis mechanism of OC at a molecular level, it is crucial to gain more insights into how metabolic and signaling alterations accompany its development. Herein, we present a comprehensive study using ultra-high-resolution Fourier transform ion cyclotron resonance matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) to investigate the spatial distribution and alterations of lipids in ovarian tissues collected from double knockout ( n = 4) and triple mutant mouse models ( n = 4) of high-grade serous ovarian cancer (HGSOC). Lipids belonging to a total of 15 different classes were annotated and their abundance changes were compared to those in healthy mouse reproductive tissue ( n = 4), mapping onto major lipid pathways involved in OC progression. From intermediate-stage OC to advanced HGSC, we provide direct visualization of lipid distributions and their biological links to inflammatory response, cellular stress, cell proliferation, and other processes. We also show the ability to distinguish tumors at different stages from healthy tissues via a number of highly specific lipid biomarkers, providing targets for future panels that could be useful in diagnosis.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.<br /> (Copyright © 2024 Ma, Botros, Yun, Park, Kim, Park, Pham, Chen, Palaniappan, Matzuk, Kim and Fernández.)

Details

Language :
English
ISSN :
2296-2646
Volume :
11
Database :
MEDLINE
Journal :
Frontiers in chemistry
Publication Type :
Academic Journal
Accession number :
38260043
Full Text :
https://doi.org/10.3389/fchem.2023.1332816